Alopecia Areata Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a male between 18 and 50 years old with male-pattern baldness (the common type of hair loss in men)
- Your hair loss is mild to moderate in extent (confirm with trial site)
- You have never used hair loss treatments before, or you are willing to stop any current hair loss treatments for at least 1 month before joining
- You are willing and able to sign a consent form agreeing to take part
Who may not be able to join:
- You have a type of hair loss other than male-pattern baldness, such as hair loss caused by inflammation or scarring
- You have an inflammatory skin condition affecting your scalp, such as psoriasis or seborrheic dermatitis (a flaky, itchy scalp condition)
- You have used certain strong medicines that affect the immune system (including immunosuppressants, JAK inhibitors, or steroid tablets) in the last 12 months
- You have a history of serious illness affecting your kidneys, heart, or liver
- You have received chemotherapy treatment in the last 5 years
- You have a condition that affects your blood's ability to clot properly
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +201016532351
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Baseline Difference in Tissue JAK2 Protein Levels Between Balding and Non-Balding Scalp
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.